VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

CorMedix Inc. (CRMD) Total Return Calculator with Dividends Reinvested

CorMedix Inc.

Popular:

The total return for CorMedix Inc. (CRMD) stock is -32.19% over the past 12 months. So far it's down 34.87% this year. The 5-year total return is -6.93%, meaning $10,000 invested in CRMD stock 5 years ago would be worth $9,307 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CRMD 1 year ago, it would be worth $6,584 today — you'd have lost $3,416.

With Dividends Reinvested$6,584-34.16%

Price Only (No DRIP)$6,584-34.16%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CRMD

1Y$6,781-$3,219 (-32.2%)-32.2% CAGR

3Y$15,086+$5,086 (+50.9%)14.7% CAGR

5Y$9,307-$693 (-6.9%)-1.4% CAGR

10Y$4,859-$5,141 (-51.4%)-7.0% CAGR

15Y$8,082-$1,918 (-19.2%)-1.4% CAGR

20Y$5,280-$4,720 (-47.2%)-3.1% CAGR

30Y$5,280-$4,720 (-47.2%)-2.1% CAGR

CorMedix Inc. did not pay dividends during this period. Total return = price return.

Loading CRMD total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-34.87%	—	-34.87%	—	$6,513
1Y	-32.19%	-32.19%	-32.19%	—	$6,781
3Y	+50.86%	14.69%	+50.86%	—	$15,086
5Y	-6.93%	-1.43%	-6.93%	—	$9,307
10Y	-51.41%	-6.96%	-51.41%	—	$4,859
15Y	-19.18%	-1.41%	-19.18%	—	$8,082
20Y	-47.20%	-3.14%	-47.20%	—	$5,280
30Y	-47.20%	-2.11%	-47.20%	—	$5,280

Risk & Highlights

Best Year+176.92%2012

Worst Year-84.36%2011

Max Drawdown-62.26%2025-06-23 → 2026-03-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-41.37%	-41.37%	—	+0.41%	-41.8pp
2025	+41.48%	+41.48%	—	+16.64%	+24.8pp
2024	+114.85%	+114.85%	—	+24.00%	+90.9pp
2023	-10.05%	-10.05%	—	+24.81%	-34.9pp
2022	-12.99%	-12.99%	—	-19.95%	+7.0pp

CRMD underperformed the S&P 500 by 62.56pp over the past year (-32.19% vs +30.37%).

Loading summary...

CRMD Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CRMDCorMedix Inc.	$621M	+10.5%	-34.9%	-32.2%	—	+50.9%	-6.9%	-51.4%
NKTRNektar Therapeutics	$1.7B	+9.4%	+92.0%	+818.2%	—	+621.8%	-72.3%	-59.1%
HALOHalozyme Therapeutics, Inc.	$7.7B	+2.5%	-7.3%	-7.1%	—	+115.3%	+37.0%	+570.7%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
ACADACADIA Pharmaceuticals Inc.	$3.9B	+2.2%	-13.7%	+52.4%	—	+4.7%	+7.1%	-22.9%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	+2.6%	+5.7%	+69.0%	—	+42.1%	+78.0%	+228.4%
PCRXPacira BioSciences, Inc.	$930M	+4.9%	-3.4%	-6.1%	—	-44.1%	-62.6%	-51.2%
AVNSAvanos Medical, Inc.	$1.2B	+80.9%	+121.6%	+96.9%	—	+5.6%	-39.8%	-17.0%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
MASIMasimo Corporation	$9.3B	-0.1%	+40.1%	+18.9%	—	-4.9%	-20.4%	+282.9%
ANGOAngioDynamics, Inc.	$469M	+16.2%	-11.1%	+28.5%	—	+25.8%	-53.3%	-9.2%

Compare:CRMD vs NKTR CRMD vs HALO CRMD vs PRAX CRMD vs NKTR vs HALO

About CRMD Dividend Returns

CorMedix Inc. (CRMD) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CRMD over the past year?

CorMedix Inc. (CRMD) delivered a return of -32.19% over the past year. Since CRMD does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CRMD be worth today?

A $10,000 investment in CorMedix Inc. one year ago would be worth $6,781 today, representing a loss of $3,219.

Q3Does CRMD pay dividends?

CorMedix Inc. (CRMD) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CRMD, the total return equals the price-only return.

Q4Did CRMD beat the S&P 500?

No, CorMedix Inc. (CRMD) underperformed the S&P 500 by 62.56 percentage points over the past year. CRMD delivered a total return of -32.19%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed CRMD by 62.56pp during this period.

Q5What is CRMD's worst drawdown?

CorMedix Inc. (CRMD) experienced a maximum drawdown of -62.26% over the past year, declining from its peak on 2025-06-23 to its trough on 2026-03-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CRMD's long-term total return over 10, 20, or 30 years?

Here are CorMedix Inc. (CRMD)'s long-term returns with dividends reinvested. Over 10 years, the total return is -51.4% (-7.0% CAGR) — $10,000 would have grown to $4,859. Over 20 years: -47.2% total return (-3.1% CAGR) — $10,000 → $5,280. Over 30 years: -47.2% total return (-2.1% CAGR) — $10,000 → $5,280. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CRMD's best and worst year?

CorMedix Inc.'s best calendar year was 2012 with a total return of 176.9%. Its worst year was 2011 with a total return of -84.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 261.3 percentage points.